Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$41.82 - $66.71 $547,340 - $873,100
-13,088 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$90.12 - $152.23 $450,600 - $761,150
5,000 Added 61.82%
13,088 $1.25 Million
Q3 2018

Nov 14, 2018

SELL
$189.1 - $282.92 $567,300 - $848,760
-3,000 Reduced 27.06%
8,088 $1.97 Million
Q2 2018

Aug 13, 2018

SELL
$123.8 - $192.48 $557,100 - $866,160
-4,500 Reduced 28.87%
11,088 $2.07 Million
Q4 2017

Feb 14, 2018

SELL
$93.4 - $128.74 $233,500 - $321,850
-2,500 Reduced 13.82%
15,588 $1.86 Million
Q3 2017

Nov 13, 2017

BUY
$91.08 - $104.49 $1.65 Million - $1.89 Million
18,088
18,088 $1.72 Million

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $218M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Formula Growth LTD Portfolio

Follow Formula Growth LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

News

Stay updated on Formula Growth LTD with notifications on news.